EUVIMEDEUVIMED entdecken
Crossref

Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis

Xiaolong Cai, Ying Bai, Chao Liang, Jiawei Zhou, Yafeng Liu, Jianqiang Guo, Yifan Jing, Yujing Fang, Xiaofei Hu, Jing Wu, Dong Hu

International Immunopharmacology · 2025-04 · 153 · 114458

DOI: 10.1016/j.intimp.2025.114458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-04. Verfasst von Xiaolong Cai und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Anhui University of Science and Technology, Huainan City, China; Anhui Province Engineering Laboratory of Occupational Health and…. Hauptthemen laut MEDLINE: Alkaloids, STAT3 Transcription Factor, Silicosis, Janus Kinase 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Anhui University of Science and Technology, Natural Science Foundation of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Silicosis, a pervasive and life-threatening occupational respiratory disease, poses a substantial global health burden, particularly affecting those in impacted communities and their families. Characterized by irreversible pulmonary fibrosis, the disease's complex pathogenesis remains poorly elucidated, presenting significant challenges for therapeutic intervention. This study integrates bioinformatics, network pharmacology, and experimental validation to explore the potential mechanisms and therapeutic drugs for silicosis. Initially, differentially expressed genes (DEGs) in silicosis were subjected to GO and KEGG pathway enrichment analysis. Subsequently, the DEGs were imported into the cMap database for drug prediction, leading to the identification of piperine (PIP) as a candidate drug for the treatment of silicosis. Network pharmacology analysis then determined the pharmacological targets of PIP and demonstrated its ability to modulate the JAK2-STAT3 signaling pathway. Finally, we validated the therapeutic effects and mechanisms of PIP in silicosis. In vivo, PIP significantly ameliorated inflammation and fibrosis induced by crystalline silica (CS) in a murine model of silicosis, including inflammatory cell infiltration, formation of inflammasomes, deposition of collagen fibers and extracellular matrix, and expression of inflammatory and fibrotic factors. In vitro, PIP inhibited CS-induced cytokine expression, ROS generation, macrophage apoptosis, and activation of the JAK2-STAT3 signaling pathways. Collectively, our research identifies and validates PIP as a promising candidate for the improvement of silicosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkaloidsSTAT3 Transcription FactorSilicosisJanus Kinase 2BenzodioxolesPolyunsaturated AlkamidesPiperidinesPulmonary FibrosisAnti-Inflammatory AgentsAnimalsSignal TransductionMiceHumansSilicon DioxideMice, Inbred C57BLDisease Models, AnimalInflammationMaleLungCytokinesRAW 264.7 CellsApoptosis

Stichwörter der Autor:innen

Drug discoveryFibrosisInflammationPIPSilicosis

Substanzen

AlkaloidsSTAT3 Transcription FactorJanus Kinase 2piperineBenzodioxolesPolyunsaturated AlkamidesPiperidinesSilicon DioxideAnti-Inflammatory AgentsJak2 protein, mouse

Autor:innen und Institutionen

  • School of Medicine, Anhui University of Science and Technology, Huainan City, China; Anhui Province Engineering Laboratory of Occupational Health and Safety, School of Medicine, Anhui University of Science and Technolog…
  • School of Medicine, Anhui University of Science and Technology, Huainan City, China; Key Laboratory of Industrial Dust Deep Reduction and Occupational Health and Safety of Anhui Higher Education Institutes, School of Me…
  • School of Medicine, Anhui University of Science and Technology, Huainan City, China; The First Affiliated Hospital of Anhui University of Science and Technology (Huainan First People's Hospital), School of Medicine, Hua…

Förderung

  • National Natural Science Foundation of China
  • Anhui University of Science and Technology
  • Natural Science Foundation of Anhui Province

Zitieren

APA

Cai, X., Bai, Y., Liang, C., Zhou, J., Liu, Y., Guo, J., Jing, Y., Fang, Y., Hu, X., Wu, J., & Hu, D. (2025). Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis. International Immunopharmacology, 153, 114458. https://doi.org/10.1016/j.intimp.2025.114458

Vancouver

Cai X, Bai Y, Liang C, Zhou J, Liu Y, Guo J, et al. Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis. International Immunopharmacology. 2025;153:114458. doi:10.1016/j.intimp.2025.114458

BibTeX
@article{Cai2025,
  author = {Cai, Xiaolong and Bai, Ying and Liang, Chao and Zhou, Jiawei and Liu, Yafeng and Guo, Jianqiang and Jing, Yifan and Fang, Yujing and Hu, Xiaofei and Wu, Jing and Hu, Dong},
  title = {Piperine as a promising therapeutic agent for silicosis: Targeting the JAK2-STAT3 signaling pathway and alleviating inflammation and fibrosis},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {153},
  pages = {114458},
  doi = {10.1016/j.intimp.2025.114458}
}
Kostenlos starten →